These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16619030)

  • 1. The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner.
    Moorthy AK; Savinova OV; Ho JQ; Wang VY; Vu D; Ghosh G
    EMBO J; 2006 May; 25(9):1945-56. PubMed ID: 16619030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural motifs involved in ubiquitin-mediated processing of the NF-kappaB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domain.
    Orian A; Schwartz AL; Israël A; Whiteside S; Kahana C; Ciechanover A
    Mol Cell Biol; 1999 May; 19(5):3664-73. PubMed ID: 10207090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of ubiquitin-mediated, limited processing of the NF-kappaB1 precursor protein p105.
    Ciechanover A; Gonen H; Bercovich B; Cohen S; Fajerman I; Israël A; Mercurio F; Kahana C; Schwartz AL; Iwai K; Orian A
    Biochimie; 2001; 83(3-4):341-9. PubMed ID: 11295495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit.
    Lin L; Ghosh S
    Mol Cell Biol; 1996 May; 16(5):2248-54. PubMed ID: 8628291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A short binding site in the KPC1 ubiquitin ligase mediates processing of NF-κB1 p105 to p50: A potential for a tumor-suppressive PROTAC.
    Goldhirsh G; Kravtsova-Ivantsiv Y; Satish G; Ziv T; Brik A; Ciechanover A
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34873064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p105 NF-ĸB precursor is a pseudo substrate of the ubiquitin ligase FBXO7, and its binding to the ligase stabilizes it and results in stimulated cell proliferation.
    Udasin RG; Gottfried Y; Fabre B; Bercovich B; Ziv T; Ciechanover A
    Biochem Biophys Res Commun; 2021 Jun; 558():224-230. PubMed ID: 32933748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-kappaB precursor.
    Kravtsova-Ivantsiv Y; Cohen S; Ciechanover A
    Mol Cell; 2009 Feb; 33(4):496-504. PubMed ID: 19250910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two distinct ubiquitin-dependent mechanisms are involved in NF-kappaB p105 proteolysis.
    Cohen S; Lahav-Baratz S; Ciechanover A
    Biochem Biophys Res Commun; 2006 Jun; 345(1):7-13. PubMed ID: 16678126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growth.
    Kravtsova-Ivantsiv Y; Shomer I; Cohen-Kaplan V; Snijder B; Superti-Furga G; Gonen H; Sommer T; Ziv T; Admon A; Naroditsky I; Jbara M; Brik A; Pikarsky E; Kwon YT; Doweck I; Ciechanover A
    Cell; 2015 Apr; 161(2):333-47. PubMed ID: 25860612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processing of p105 is inhibited by docking of p50 active subunits to the ankyrin repeat domain, and inhibition is alleviated by signaling via the carboxyl-terminal phosphorylation/ ubiquitin-ligase binding domain.
    Cohen S; Orian A; Ciechanover A
    J Biol Chem; 2001 Jul; 276(29):26769-76. PubMed ID: 11350967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.
    Heissmeyer V; Krappmann D; Hatada EN; Scheidereit C
    Mol Cell Biol; 2001 Feb; 21(4):1024-35. PubMed ID: 11158290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappa B p105 processing via the ubiquitin-proteasome pathway.
    Sears C; Olesen J; Rubin D; Finley D; Maniatis T
    J Biol Chem; 1998 Jan; 273(3):1409-19. PubMed ID: 9430676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-κB precursor.
    Kravtsova-Ivantsiv Y; Cohen S; Ciechanover A
    Adv Exp Med Biol; 2011; 691():95-106. PubMed ID: 21153313
    [No Abstract]   [Full Text] [Related]  

  • 14. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.
    Belich MP; Salmerón A; Johnston LH; Ley SC
    Nature; 1999 Jan; 397(6717):363-8. PubMed ID: 9950430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for phosphorylation in the proteolytic processing of the human NF-kappa B1 precursor.
    Fujimoto K; Yasuda H; Sato Y; Yamamoto K
    Gene; 1995 Nov; 165(2):183-9. PubMed ID: 8522173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
    Palombella VJ; Rando OJ; Goldberg AL; Maniatis T
    Cell; 1994 Sep; 78(5):773-85. PubMed ID: 8087845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase.
    Orian A; Gonen H; Bercovich B; Fajerman I; Eytan E; Israël A; Mercurio F; Iwai K; Schwartz AL; Ciechanover A
    EMBO J; 2000 Jun; 19(11):2580-91. PubMed ID: 10835356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A20 inhibits both the degradation and limited processing of the NF-κB p105 precursor: A novel additional layer to its regulator role.
    Lapid D; Lahav-Baratz S; Cohen S
    Biochem Biophys Res Commun; 2017 Nov; 493(1):52-57. PubMed ID: 28923245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The generation of nfkb2 p52: mechanism and efficiency.
    Heusch M; Lin L; Geleziunas R; Greene WC
    Oncogene; 1999 Nov; 18(46):6201-8. PubMed ID: 10597218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-mediated processing of NF-kappa B transcriptional activator precursor p105. Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation.
    Orian A; Whiteside S; Israël A; Stancovski I; Schwartz AL; Ciechanover A
    J Biol Chem; 1995 Sep; 270(37):21707-14. PubMed ID: 7665588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.